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Abstract
Background: Chagas disease is endemic in the rural areas of southern Peru and a growing urban problem in the regional
capital of Arequipa, population ,860,000. It is unclear how to implement cost-effective screening programs across a large
urban and periurban environment.
Methods: We compared four alternative screening strategies in 18 periurban communities, testing individuals in houses
with 1) infected vectors; 2) high vector densities; 3) low vector densities; and 4) no vectors. Vector data were obtained from
routine Ministry of Health insecticide application campaigns. We performed ring case detection (radius of 15 m) around
seropositive individuals, and collected data on costs of implementation for each strategy.
Results: Infection was detected in 21 of 923 (2.28%) participants. Cases had lived more time on average in rural places than
non-cases (7.20 years versus 3.31 years, respectively). Significant risk factors on univariate logistic regression for infection
were age (OR 1.02; p=0.041), time lived in a rural location (OR 1.04; p=0.022), and time lived in an infested area (OR 1.04;
p=0.008). No multivariate model with these variables fit the data better than a simple model including only the time lived
in an area with triatomine bugs. There was no significant difference in prevalence across the screening strategies; however a
self-assessment of disease risk may have biased participation, inflating prevalence among residents of houses where no
infestation was detected. Testing houses with infected-vectors was least expensive. Ring case detection yielded four
secondary cases in only one community, possibly due to vector-borne transmission in this community, apparently absent in
the others.
Conclusions: Targeted screening for urban Chagas disease is promising in areas with ongoing vector-borne transmission;
however, these pockets of epidemic transmission remain difficult to detect a priori. The flexibility to adapt to the
epidemiology that emerges during screening is key to an efficient case detection intervention. In heterogeneous urban
environments, self-assessments of risk and simple residence history questionnaires may be useful to identify those at
highest risk for Chagas disease to guide diagnostic efforts.
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Introduction
Chagas disease has historically occurred in poor rural settings of
Latin America [1,2,3]. In the rural areas of the Department of
Arequipa in southern Peru, reports of Chagas disease and its
vectors date back to the early 20
th century [4,5,6], where the
disease has persisted in an endemic state [7]. However, recent case
reports [8] and epidemiologic studies [9,10] have documented
emerging vectorial transmission of Trypanosoma cruzi, the etiologic
agent of Chagas disease, in communities of the urban capital of
Arequipa. As T. cruzi and Triatoma infestans, the sole insect vector in
this setting, spread through the city of Arequipa (pop. 864,250)
[11,12], several hundred thousand people are at risk of infection.
Most individuals have mild or no symptoms during the acute
phase of Chagas disease, and pass into the chronic phase without
having the infection detected. In the chronic phase, most infected
individuals show no signs or symptoms and are considered to have
the indeterminate form of the disease. An estimated 20–30% of
infected individuals will later develop the cardiac or digestive
forms of chronic Chagas disease. Advanced cardiac or digestive
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for patients with the indeterminate form or early cardiomyopathy,
antitrypanosomal treatment is reported to decrease the probability
of disease progression [15].
It is important to detect individuals with chronic T. cruzi
infection because they need clinical attention, may be candidates
for treatment, and pose risk for further transmission – either
vectorial, congenitally or through blood donation [16,17,18].
Diagnostics for Chagas disease in southern Peru are expensive
relative to local income and the limited government budget for
vector-borne disease control [19]. Alarmed by the urban
encroachment of T. infestans, the Arequipa regional Ministry of
Health (MOH) recommends universal testing of all residents of
communities with T. cruzi-infected T. infestans. However, such
wide-scale testing is too costly for practical implementation.
Population screening is further challenged by the very low
sensitivity of field-applicable rapid tests in Arequipa, and screening
must employ high sensitivity conventional tests such as enzyme-
linked immunosorbent assays [20]. Given the large population of
Arequipa city and limited health resources, targeted interventions
are the only viable option to screen for chronic T. cruzi infection in
this population.
Although mass vector-control campaigns have had success in
Latin America [21,22], numerous authors call for improved
screening strategies and expansion of treatment for persons with
Chagas disease [19,23,24], stressing the importance of cost-
efficiency, sustainability, and integration of sectors [22,25]. Several
cost-effectiveness studies of Chagas disease interventions have
focused on devising optimal insecticide application and blood
donor testing schemes [25,26,27,28], but few have examined
strategies for human serologic testing in endemic or epidemic
areas. A study by Mott et al. [29] indicated the potential for
targeted screening around detected positive children under 5 years
of age in a rural area of Brazil. Gurtler et al. [19,30] highlight the
potential efficiency of linking serologic screening to vector control
campaigns. It remains unclear how to implement cost-effective,
targeted screening programs across a large and diverse urban
environment with dynamic vector infestation.
In one periurban community of Arequipa that was heavily
infested with T. infestans, 5.3% of children had T. cruzi infection
[31]. Age-prevalence curves of infection [10] and the spatial
distribution of cases suggested that the disease was in an epidemic
phase in this community [31]. A retrospective analysis of
household vector data carefully collected during an insecticide-
application campaign prior to serologic testing, indicated that a
two-step targeted screening intervention based on household
entomologic risk factors and ring testing around identified cases
would have captured 83% of infected children, while minimizing
the testing of negative children [31]. In the present operational
research study, we test 4 targeted screening strategies based on
similar household entomologic data, and one adaptive spatial
strategy, in 18 periurban communities of Arequipa, Peru. We
compare the performance and cost of each, and evaluate the
patterns of infection they reveal. Our objective was to test the
operational feasibility of routinely collected data from vector
control campaigns for human Chagas disease detection on a larger
urban scale.
Methods
Study setting
This cross-sectional study was conducted in 3 districts of the city
of Arequipa. Each district is composed of several communities,
which span a gradient of development. In general, there are higher
quality housing materials and infrastructure in the parts closer to
the urban center and more recent, less developed settlements
towards the periphery.
As part of a coordinated Chagas control campaign, Ministry of
Health (MOH) vector control teams applied two rounds of
deltamethrin insecticide (5% Wettable Powder; K-Othrine,
Bayer; target dose of 25 mg a.i./m
2), spaced six months apart,
to houses in 92 communities across the 3 study districts between
2005 and 2009. The insecticide has an immediate repellent effect,
and a delayed lethal effect, on the triatomine bugs. Technicians
were trained by the MOH to collect as many emerging
triatomine bugs as possible from each house at the time of
spraying, thereby obtaining a sample of vectors infesting the
house. All technicians were overseen by a brigade chief
experienced in Chagas disease vector control. The insects were
placed in containers coded by household and delivered to the
study laboratory in Arequipa for microscopic examination for
T.cruzi, as described previously [9]. Of the 92 communities
participating in the insecticide campaign, T. cruzi-infected
triatomines were detected in only 18 communities (19.6%, 95%
CI: 11.5–27.6). We limited our targeted screening strategies to
residents of these 18 communities in which the etiologic agent of
Chagas disease had been documented.
Selection of households
We tested the following four targeted and mutually exclusive
strategies for use in the initial screening step, based on household
vector data collected at the time of the MOH spray campaign in
the 18 communities. Each strategy grouped households on a
gradient of risk for human T. cruzi infection based on information
from prior studies [10], in the order listed below.
N Infected vector: Houses with T. cruzi-infected T. infestans (100% of
eligible houses approached)
N High vector density, uninfected: Houses with only uninfected vectors
collected in quantities at or above the 90
th percentile of the
total vector count specific to that house’s community (25% of
eligible houses approached, randomly selected)
Author Summary
In the wake of emerging T. cruzi infection in children of
periurban Arequipa, Peru, we conducted a prospective
field trial to evaluate alternative targeted screening
strategies for Chagas disease across the city. Using insect
vector data that is routinely collected during Ministry of
Health insecticide application campaigns in 3 periurban
districts of Arequipa, we separated into 4 categories those
households with 1) infected vectors; 2) high vector
densities; 3) low vector densities; and 4) no vectors.
Residents of all infected-vector households and a random
sample of those in the other 3 categories were invited for
serological screening for T. cruzi infection. Subsequently,
all residents of households within a 15-meter radius of
detected seropositive individuals were invited to be
screened in a ring case-detection scheme. Of 923
participants, 21 (2.28%) were seropositive. There were no
significant differences in prevalence across the 4 screening
strategies, indicating that household entomologic factors
alone could not predict the risk of infection. Indeed, the
most predictive variable of infection was the number of
years a person lived in a location with triatomine insects.
Therefore, a simple residence history questionnaire may be
a useful screening tool in large, diverse urban environ-
ments with emerging Chagas disease.
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collected in quantities below the 90
th percentile of the total
vector count specific to that house’s community (1% of eligible
houses approached, randomly selected)
N Uninfested: Houses in which no T.infestans were detected at the
time of spraying (1% eligible houses approached, randomly
selected)
Figure 1 presents a flowchart of the process by which vector
data were used to separate the sprayed households into each
targeted screening strategy. Sampling percentages for each
strategy were chosen to stay within the sample size of the study.
Random selection of houses was carried out using a random
number generator code in Stata 10 (StataCorp) applied to a list of
all houses in each category.
Following this initial screening step, the second step consisted of
adaptive ring sampling in which testing was offered to the
inhabitants of all houses within 15 meters of a seropositive
individual detected through one of the above strategies. City
block layouts are such that houses are contiguous (share one or
more walls). A radius of 15 meters would allow to capture, on
average, 5 immediate neighbors per index house (two lateral
neighbors, one neighbor behind the house and two diagonal
neighbors). We subsequently tested another 15 meter radius
around any secondary seropositive individuals detected during
the adaptive sampling.
There had been no insecticide-application campaigns in any of
the study sites prior to the 2005–2009 campaigns described here.
Houses that were not sprayed during the vector-control campaign
could not be assigned to the vector-based strategies, and were
excluded. However, they were eligible for the adaptive ring testing.
Within the randomized strategies, households that refused to
participate in the serology were replaced by additional random
selections until reaching the enrollment goal for each strategy.
Refusal events were recorded and some reasons for refusal noted.
Household participation was defined as participation by at least 1
member. Households were mapped using GoogleEarth (Google
Inc.) and ArcGIS 9.3.1 (ESRI, 1999–2008).
Ethics statement
The study was approved by the human subjects research ethics
committees of Johns Hopkins Bloomberg School of Public Health
and by the Universidad Peruana Cayetano Heredia in Peru.
Signed informed consent was obtained prior to participation by all
adults and the parents of all participating children ,18 years. In
addition to their parent’s consent, children $7 years old provided
signed informed assent prior to participating.
Recruitment of participants
Trained field workers approached each selected house and
explained the entire study. In addition, they informed residents
about the specific vector data obtained from their house during the
spray campaign. For example, residents of households in the
infected vector strategy were informed that triatomines collected
from their homes carried the parasite that causes Chagas disease.
Each house’s vector data was kept confidential and not shared
with any other household; potential participants were only
informed of the community-level risk, for example that T. cruzi
Figure 1. Flowchart of household selection into targeted screening strategies for Chagas disease based on vector-control data.
Figure 1 displays the scheme used to stratify households into 4 targeted strategies to screen household members for human T. cruzi infection. The
stratification was based on Ministry of Health (MOH) entomologic data from recent spray campaigns and laboratory analysis in the city of Arequipa,
Peru.
1 Although 81 households had T.cruzi-infected T.infestans at the time of spray, 1 household was no longer inhabited at the time of this study,
and 2 refused to participate.
doi:10.1371/journal.pntd.0001468.g001
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All individuals $1 year old were invited to participate.
Data collection & management
Field workers conducted a brief household census with one
adult member per house, and a questionnaire about demographics
and exposure to Chagas disease risks with each individual study
participant. Demographic variables included sex, age, and
education level. Exposure variables focused on the residential
history of participants. Starting with their place of birth,
participants were asked to list and categorize each previous place
of residence (stays longer than 1 month) as rural, urban or
periurban, and to recall the presence or absence of ‘‘chirimachas’’,
the local name for T. infestans. Participant recall was aided by the
fact that T. infestans is the sole Chagas disease vector in southern
Peru and by the heightened awareness resulting from widespread
radio, print and interpersonal messaging during the spray
campaigns. This element of the questionnaire was not designed
to test participant knowledge or ability to identify T. infestans, but
to examine if recall through a simple questionnaire could be
operationally useful to identify infected or high-risk individuals. In
addition, for the purposes of informing future feasibility of this type
of screening, we collected data on the costs of fieldwork for
obtaining blood samples, specimen processing and testing, data
management and quality control. All data was double digitated
and managed in Microsoft AccessH. We logged person-hours for
each of these activities, the number of visits made to each house,
and the cost of materials and overhead. This data would yield a
simple estimate of the cost of screening strategy implementation
for operational purposes.
Specimen collection, processing and diagnostic testing
A venous blood specimen (3 ml for children younger than 5
years, 5 ml for participants 5 years or older) was collected from
each consenting participant and transported to a Chagas disease
field laboratory of the Universidad Peruana Cayetano Heredia
(UPCH) located in Arequipa. At the field laboratory, specimens
were centrifuged, aliquoted, and stored at 220uC until the time of
diagnostic testing using the Chagatek ELISA kit following the
manufacturer’s instructions for cutoffs (BioMe ´rieux). 100% of
specimens with positive results by ELISA and a randomly selected
10% with negative results were tested using immunofluorescence
assay (IFA) according to published methods [20]. Aliquots of the
same specimens were processed in parallel in the UPCH
Microbiology Laboratory in Lima for quality control. Individuals
with positive results by both ELISA and IFA were considered to
have confirmed infection. Those with positive ELISA results and
negative IFA results were considered discordant. However,
previous research has shown that ELISA-positive, IFA-negative
specimens likely indicate true infection in Arequipa [32], and
therefore for the purposes of our data analysis only we considered
individuals with discordant test results as T. cruzi infected.
Regardless of this grouping, all ELISA-positive participants were
referred to the MOH along with their lab results, for a case-by-
case evaluation of infection status and clinical management by
physicians based on national guidelines.
Statistical analysis
Participants’ demographic and exposure variables described
above were used to calculate frequencies and means, and to fit
regression models on the outcome of detected T. cruzi infection.
The total number of lifetime locations each participant had lived
in was tabulated from the migration histories, as were each
participants’ total number of years lived in a rural, periurban, or
urban locations, and in a location recalled as being infested with T.
infestans (regardless of rural, urban or periurban). Because rates of
infection were low in our sample, we used Poisson regression to
evaluate associations between covariates and infection status using
the prevalence ratios (PrR) [33,34]. Since the data were neither
over- nor under-dispersed with respect to the outcome, no
adjustments were required [34]. We fit models with a random
effect term (gamma distributed) to consider correlation among
participants of the same household. For the regression analyses,
education level was considered only for adults. All variables with
p,0.2 in univariate regression analysis were considered in fitting a
multivariate model. Statistical tests were conducted using Stata 10
(StataCorp).
Results
At the time of insecticide application in our 18 study
communities, 1980 of 7739 (25.6%, 95% CI: 24.6–26.6) sprayed
households were found to be infested with triatomine vectors, with
technicians capturing between 1–301 T. infestans per household.
The 90
th percentile cut-off between the high-density and low-
density vector houses was determined separately for each
community and ranged from 11–85 T. infestans captured per
household. Out of the 1980 households in which vectors were
detected, eighty-one (4.1%) had vectors carrying T. cruzi. In total,
923 people from 249 households participated in the serological
testing across the 18 communities in 3 districts. There were no
statistically significant differences in demographics by district (data
not shown). Participants had a mean age of 34 years (range: 1–94),
and 78.9% were adults of age 18 or over. Of the total participants,
21 (2.28%) tested positive according to ELISA, and were
considered T. cruzi infected for this analysis. Nineteen of these
also had positive results by IFA, while 2 did not. All 21 infected
individuals were over the age of 18.
Table 1 displays the results across strategies. Neither demo-
graphic characteristics nor infection prevalence differed signifi-
cantly among participants recruited through the four alternative
strategies. Although not statistically significant, the highest
prevalence was observed among those screened in houses with
no infestation detected (3.07%). However, we encountered high
refusal rates during participant recruitment from the houses with
no infestation detected. Of 97 households approached, only 59
(61%) participated. By contrast, 98% of households with T. cruzi-
infected vectors detected participated in the study. In addition, the
within household participation rate was lower for households in
which no infestation was detected versus households in the infected
vector group, 55% versus 70% participation, respectively. These
data suggest a self-selection bias in participation among people
living in houses with no infestation detected. Potential reasons for
this are explored in the discussion.
The 923 participants had lived in a mean of 2.5 locations
(range:1–15). Mean residence in a periurban location was 26.97
years (CI 25.98, 27.97), while mean residence in an urban location
was 3.61 years (CI 3.11, 4.12), and 3.39 years (CI 2.91, 3.88) in a
rural location. The T. cruzi infected human cases we detected had
lived longer, on average, in rural places than non-cases (mean 7.20
years vs. 3.31, respectively; p=0.0184).
The results of univariate analysis on T. cruzi infection status are
shown in Table 2. The probability of infection with T. cruzi
increased by 2% per year of age (p=0.02), by 2% per year lived in
a periurban location (p=0.185), by 4% per year lived in a rural
location (p=0.04), and by 4% per year lived in a place with
triatomine bugs (p=0.008). Multivariate models with combina-
tions of these variables did not fit the data better than the
Targeted Screening for Chagas Disease, Urban Peru
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all four of the above variables on calendar time, it is likely that all
are describing a similar experience of risk.
Table 1 also displays the results of the secondary case detection
by 15 meter radii. The adaptive ring sampling of houses within
15 meters of the houses of the 17 index cases yielded 4 additional
cases out of 158 individuals tested. Although employed in seven
different communities, all four of the secondary detected cases
lived in the same community, Simo ´n Bolı ´var. Of the 10 total cases
found in Simo ´n Bolı ´var, 7 had lived only in urban districts of
Arequipa, and 5 only in Simo ´n Bolı ´var itself, suggesting a local,
urban site of transmission.
The estimated costs for each study activity are shown in Table 3.
The fixed overhead cost per participant was $7.14, including field
materials, telecommunications, transportation, data management,
and diagnostic testing, and this was standard across all strategies.
However, the recruitment cost per participant varied greatly
across strategies, being a function of both the sampling framework
and differential participation rates for each. For the households
with infected-vectors detected, our field team made 1.32
Table 1. Comparison of targeted strategies to detect T. cruzi-infected individuals in 18 periurban communities, Arequipa, Peru.
Strategy name Infected vector High vector density Low vector density
Uninfested (no
infestation detected)
Adaptive ring
testing
Description Houses in which
T. cruzi was observed
in at least 1 vector
collected during
the spray campaign
Houses in the 90
th
and above percentile
of vector density in
each community
Houses below the
90
th percentile of
vector density in
each community
Houses in which
no vectors were
detected at the
time of spray
Houses within 15 m
of a confirmed
human infection
detected through
previous strategies
Total number of
households
80
1 189 1710 5759 68
2
Enrollment goal 80 (100%) 49 (25% random sample) 18 (1% random sample) 59 (1% random sample) 68 (100%)
Participating households
of total approached
3
78/80 (98%) 49/67 (73.1%) 18/21 (85.7%) 59/97 (61%) 45/68 (66.2%)
Mean number of
participants per household
4.0 4.7 4.3 2.7 3.5
Household member
participation rate out
of total members
4
70.3% 63.6% 72.3% 55.0% 62.0%
Prevalence of T. cruzi
infection among
study participants
8/308 (2.60%) 2/209 (0.96%) 2/85 (2.35%) 5/163 (3.07%) 4/158 (2.53%)
Average number of
household visits per
participant enrolled
1.32 1.41 1.48 2.63 1.78
Person-hours of fieldwork,
per participant enrolled
1.98 2.12 2.22 3.95 2.67
1Originally 81 houses had T.cruzi-infected triatomines, however 1 house was no longer inhabited at the time of this study.
227 additional households within 15 meters of an index human infection had already been approached under the previous strategies.
3Number of participating households out of total households invited to participate.
4Percent of household members participating of total household members .1 year old.
doi:10.1371/journal.pntd.0001468.t001
Table 2. Univariate Poisson regressions
1 on T. cruzi infection among targeted screening participants in Arequipa, Peru.
Variable Percent or Mean (95% CI) Prevalence Ratio (PrR) P-value N
Male 42.0% (38.8, 45.2) 1.03 0.939 923
Completed primary school
2 91.1% (89.0, 93.1) 0.94 0.924 728
Age 34.0 yrs (32.8, 35.1) 1.02 0.041 923
Lifetime number of places lived
3 2.5 places (2.3, 2.6) 1.06 0.585 923
Years lived in rural locations
3 3.4 yrs (2.91, 3.88) 1.04 0.022 923
Years lived in periurban locations
3 27.0 yrs (25.98, 27.97) 1.02 0.185 923
Years lived in urban locations
3 3.6 yrs (3.11, 4.12) 1.00 0.951 923
Years lived in locations infested with
Triatoma infestans
3
21.9 yrs (20.9, 22.9) 1.04 0.008 923
1Poisson regressions included a random effect term to control for correlation among participants from the same household.
2Univariate analysis of education includes only adults (age 18 or over).
3The lifetime total number of places in which each participant had lived was tabulated from the migration histories, as were each participants’ total number of years
lived in a rural, periurban or urban location, and in a location recalled as being infested with T. infestans.
doi:10.1371/journal.pntd.0001468.t002
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houses in which no infestation was detected, reflecting the higher
refusal rate of the latter. Each household visit required an average
of 1.54 person-hours, at which rate, the testing in houses where no
infestation was detected was the most costly strategy per
participant ($14.62 USD), and the infected-vector houses strategy
the least costly per participant ($10.91 USD).
Discussion
Chagas disease is a growing problem in Arequipa, Peru. A
previous study in the city uncovered micro-epidemics of
transmission associated with high density of vectors, suggesting
that targeting screening based on entomologic information could
be an efficient means of detecting T. cruzi infected individuals [31].
In this prospective field trial, we uncovered important differences
in the association between vector-parasite distribution and human
Chagas disease infection, which merit consideration in the design
of screening programs for Chagas in Arequipa and other urban
settings.
There are numerous reasons why the vector-based targeted
screening strategy designed for a previously studied community
(Guadalupe), yielded fewer cases when applied elsewhere in the
city. In Guadalupe, parasite infections in both humans and vectors
were clustered, and the age-prevalence curves suggested estab-
lished epidemics of T. cruzi transmission [10,31]. The present study
sites, much closer to the city center, also contained clusters of
parasite-infected vectors, but these consisted of fewer households.
These smaller clusters are likely indicative of a relatively short
history of vectorial transmission, leading to few locally acquired
cases.
In addition to epidemiology and ecology, social and demo-
graphic phenomena may also affect patterns of human Chagas
disease [35,36]. Frequent migratory movement between rural and
metropolitan Arequipa may bring parasite into the city [36,37];
the cases of infection we detected were most associated with a
history of triatomine exposure and residence in rural areas, where
Chagas disease is historically endemic [4,5,6]. It is possible that the
few clusters of parasite are due to introductions from outside that
did not manage to spread beyond a handful of households in the
new urban environment. That periurban time of residence did not
significantly contribute to overall risk of infection in this study is
another indication of minimal vectorial disease transmission in the
study communities.
Interestingly, one of the 18 communities studied, Simo ´n Bolı ´var,
did display patterns of infection reminiscent of the micro-epidemic
hotspots observed in Guadalupe. In Simo ´n Bolivar, the 4
secondary cases detected within 15 meters of index cases may
suggest significant rates of local vector-borne transmission at the
time of insecticide application. The dissimilar migration history of
the cases found in Simo ´n Bolı ´var allow us to rule out that this
clustering may be due to a group of infected migrants from the
same sending community settling on the same city block, a
phenomenon that has occurred in periurban settlements of
Arequipa [37,38]. Importantly, there was no obvious a priori
evidence in Simo ´n Bolı ´var to expect transmission to differ from the
other 17 communities considered. This study adds to growing
evidence of an uneven distribution of T. cruzi infection in the city
of Arequipa [9,10], not uncommon to this parasitic disease [39].
Other similar pockets of vector-borne transmission may exist in
the city; the implementation of small pilot studies in infested areas
followed by spatial adaptive sampling around human cases can
help uncover them and determine the appropriate screening
strategy for each setting. Where urban vectorial transmission is
present, this adaptive strategy identifies secondary cases efficiently.
When employed in an area without vectorial transmission,
adaptive sampling should return few or no secondary cases, such
that additional screening is curtailed and expenditures capped.
Although harder to obtain, longitudinal entomological data, as
opposed to the cross-sectional data utilized here, may be
informative in locating these mini-epidemics. We are currently
exploring community-based recognition and alert systems as a
promising mechanism for obtaining this longitudinal vector data.
In addition, our disease screening activities took place between 5
months and 4 years after household insecticide application and
collection of the entomologic data. It is not clear what the effect of
this time lapse may be on the association between vector data and
human infections detected. The strategies may work much better if
these delays were eliminated. However, considering that exposure
risk is greatly reduced by the elimination of vectors, we can
reasonably expect that there were little new infections prior to our
testing.
Another possible cause of error is the inability of migration
histories to capture participants’ short visits to endemic areas.
While a potentially important source of exposure, there are
methodological and recall challenges to documenting travel
history at such a fine level. We found that screening based on
personal risk assessment and residence-exposure history (ie, time
Table 3. Total expenditures to conduct targeted screening for T. cruzi infection in Arequipa, Peru, all strategies.
Activity
1 Cost of activity per study participant
2
Fieldwork Person-hours spent on household visits for recruitment
and study enrollment (variable by strategy)
Min: $3.77 (Infected vector); Max: $7.48
(No infestation detected)
Materials, transportation, and telecommunications $1.47
Data management Person-hours for double data entry $1.28
Laboratory work Diagnostic test materials and reagents $3.00
Person-hours for human specimen processing,
diagnostic and confirmation testing
$1.39
Total cost per study participant Min: $10.91 (Infected vector); Max:
$14.62 (No infestation detected)
1Total expenditure based on the salary for fieldworkers, data managers, or lab workers, respectively, at the time of the study.
2Exchange rate of 3.00 Peruvian Nuevo Soles (PEN) to the U.S. dollar (USD).
doi:10.1371/journal.pntd.0001468.t003
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high-risk individuals. Studies of blood donors in Canada and the
US have found promising usefulness and operational feasibility of
residence history questionnaires [26,27,40].
Our study consisted of operational research in a large
heterogeneous city. In the wake of vector control campaigns, the
target population was well-aware of their risk of Chagas disease.
Residents of houses where no infestation was detected could have
been at risk of vectorial transmission due to proximity to infested
houses. However, during our fieldwork, it became clear that those
who participated in this optional Chagas disease screening did so
because they believed themselves to be at risk due to prior
exposure. Participants from houses with no infestation detected
often expressed concern about a previous infestation in their
current or prior homes. In contrast, those who refused often
reported being uninterested in testing because they did not
consider themselves at risk, or because in their memory they had
no contact with a vector. As a result, this study suffered from a self-
selection bias according to perceived risk among participants living
in vector-free houses at the time of the spray campaign. This bias
likely caused an overestimate of the Chagas disease prevalence in
houses with no infestation detected. Although not directly
comparable, our observed overall prevalence of 2.28% is much
higher than the 0.73% reported in a 2004–05 cross-sectional
screening of pregnant women in Arequipa, which included
populations from communities also studied here [41]. In contrast,
we believe the prevalence estimate of 2.60% among the infected
vector group to be quite accurate for persons living in this risk
category due to the 98% participation rate.
Factors affecting participation need to be taken into consider-
ation to design an economically optimal algorithm for targeted
screening of Chagas disease. The high refusal rate among houses
with no infestation detected required double the number of
household visits per participant recruited than for the infected-
vector group, making it the most expensive strategy in our cost
calculation. If similar entomologic data from vector control
campaigns are used to guide a human Chagas disease case-finding
strategy, minimizing costs for fieldwork while still detecting cases
would be optimal. Targeting screening according to the presence
of T. cruzi-infected T. infestans was less expensive and similarly
effective compared to the other strategies. Further, coupling
screening to ongoing vector control campaigns can improve
participation [19] with the added advantage of eliminating the
time lapse between entomologic data and human testing that we
experienced in some communities of this study.
In large cities like Arequipa, where T. cruzi exposure is highly
heterogeneous, a targeted screening program is necessary for the
prompt diagnosis of indeterminate Chagas disease, the prevention
of future transmission and the maximization of limited resources
[19]. A greater knowledge of the patterns of infection can be
obtained by pilot studies, and would improve the design of
screening strategies. Rural, urban and periurban places have
different ecologies, and it is reasonable to expect different
epidemiologies of Chagas disease in these settings [42]. The
flexibility to adapt to the epidemiology that emerges during pilot
screenings is key to an efficient case detection intervention. Finally,
this data can help develop a brief residence history questionnaire
for referring to diagnostic testing those at greatest risk of Chagas
disease. Self-assessment of risk and triatomine exposure time is a
potentially useful tool for screening; volunteer screening programs
at local health posts or fairs may be very effective ways to capture
infections in heterogeneous periurban communities subsequent to
informative vector control campaigns.
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